Detalhe da pesquisa
1.
Vaccinations are not associated with inhibitor development in boys with severe haemophilia A.
Haemophilia
; 24(2): 283-290, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-29243367
2.
Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors-A retrospective analysis.
Haemophilia
; 24(2): 245-252, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-29436077
3.
Immunogenicity, efficacy and safety of Nuwiq® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect Study.
Haemophilia
; 24(2): 211-220, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-28815880
4.
Pharmacokinetics of a novel extended half-life glycoPEGylated factor IX, nonacog beta pegol (N9-GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials.
Haemophilia
; 23(4): 547-555, 2017 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-28233381
5.
Comparing the burden of illness of haemophilia between resource-constrained and unconstrained countries: the São Paulo-Toronto Hemophilia Study.
Haemophilia
; 23(5): 682-688, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28440005
6.
Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective.
Haemophilia
; 23(1): 11-24, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-27633342
7.
The role of previously untreated patient studies in understanding the development of FVIII inhibitors.
Haemophilia
; 22(1): 22-31, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26315604
8.
An institutional pilot study to investigate physical activity patterns in boys with haemophilia.
Haemophilia
; 22(5): e383-9, 2016 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-27530715
9.
Pilot study of once-a-day prophylaxis for youth and young adults with severe haemophilia A.
Haemophilia
; 22(5): e401-5, 2016 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-27481574
10.
Pharmacokinetic characterization of recombinant factor XIII (FXIII)-A2 across age groups in patients with FXIII A-subunit congenital deficiency.
Haemophilia
; 21(3): 380-385, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25643920
11.
Changing paradigm of prophylaxis with longer acting factor concentrates.
Haemophilia
; 20 Suppl 4: 99-105, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24762284
12.
Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders.
Haemophilia
; 20(2): 158-67, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23937614
13.
Incidence and risk factors for inhibitor development in previously untreated severe haemophilia A patients born between 2005 and 2010.
Haemophilia
; 20(6): 771-6, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25039669
14.
Intracranial haemorrhage in von Willebrand disease: a report on six cases.
Haemophilia
; 19(4): 602-6, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23556472
15.
Prophylaxis re-visited: The potential impact of novel factor and non-factor therapies on prophylaxis.
Haemophilia
; 24(6): 845-848, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29989273
16.
Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).
Haemophilia
; 19(1): 76-81, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22823000
17.
DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype.
Haemophilia
; 18(1): 50-5, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-21592259
18.
An International Prophylaxis Study Group (IPSG) survey of prophylaxis in inhibitor positive children/adults with severe haemophilia.
Haemophilia
; 23(5): e444-e447, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28439934
19.
An International Prophylaxis Study Group (IPSG) survey of prophylaxis in adults with severe haemophilia.
Haemophilia
; 23(5): e447-e450, 2017 09.
Artigo
Inglês
| MEDLINE | ID: mdl-28429874
20.
Switching to extended half-life products in Canada - preliminary data.
Haemophilia
; 23(4): e365-e367, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28548284